Exchange Traded Concepts’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Exchange Traded Concepts’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$25.4M	Buy	+252,840	New	+$25.9M	0.1%	177

Other funds holding IHE

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

MinichMacGregor Wealth Management Saratoga Springs, New York $620M AUM 32.35% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return

Prospera Financial Services Dallas, Texas $7.73B AUM 29.41% 1-Year Est. Return

McElhenny Sheffield Capital Management Dallas, Texas $431M AUM 6.99% 1-Year Est. Return

Arkansas Financial Group Little Rock, Arkansas $751M AUM 9.21% 1-Year Est. Return

Well Done LLC Holland, Michigan $732M AUM 14.62% 1-Year Est. Return

Virtue Capital Management Brentwood, Tennessee $768M AUM 30.82% 1-Year Est. Return

Advisornet Financial Minnetonka, Minnesota $2.21B AUM 14.38% 1-Year Est. Return

Exchange Traded Concepts's IHE Position: Q3 2026 in Review

Exchange Traded Concepts opened a new position in iShares US Pharmaceuticals ETF (IHE) in Q3 2026: 252,840 shares worth $25.4M. The stake represents 0.1% of the portfolio and ranks #177 among its holdings.

145 funds tracked by Wall St. Rank hold IHE as of Q3 2026.

Exchange Traded Concepts held 252,840 shares of iShares US Pharmaceuticals ETF worth $25.4M as of Q3 2026.
iShares US Pharmaceuticals ETF was a new Exchange Traded Concepts position in Q3 2026.
iShares US Pharmaceuticals ETF made up 0.1% of Exchange Traded Concepts's portfolio in Q3 2026, its #177 holding.
145 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2026.

Based on Exchange Traded Concepts's 13F filing for Q3 2026, filed 28 Oct 2026.